The road to digital transformation for clinical trials has been slower than US FDA leaders would like, but overcoming these challenges is a shared responsibility borne by all entities in the research process and not just contract research organizations, representatives from the CRO industry say.
In interviews with the Pink Sheet, Doug Peddicord, executive director of the Association of Clinical Research Organizations (ACRO), and Jackie Kent, senior vice president of product at the digital services provider Medidata Solutions Inc